Literature DB >> 6440902

A highly sensitive enzyme-linked immunosorbent assay to quantitate antibodies to Epstein-Barr virus membrane antigen gp340.

B J Randle, M A Epstein.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) has been developed for the detection of antibodies to Epstein-Barr (EB) virus membrane antigen (MA) glycoprotein, gp340, in tamarins. The assay was found to be a thousand-fold more sensitive than conventional indirect immunofluorescence tests and consequently it was possible to follow accurately the sequential production of specific antibodies to gp340 by tamarins during a course of immunization.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6440902     DOI： 10.1016/0166-0934(84)90026-0

Source DB:  PubMed          Journal:  J Virol Methods        ISSN： 0166-0934            Impact factor:   2.014


  6 in total

1.  Mapping of B-cell epitopes on the polypeptide chain of the Epstein-Barr virus major envelope glycoprotein and candidate vaccine molecule gp340.

Authors:  R J Pither; C X Zhang; C Shiels; J Tarlton; S Finerty; A J Morgan
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

2.  Not all potently neutralizing, vaccine-induced antibodies to Epstein-Barr virus ensure protection of susceptible experimental animals.

Authors:  M A Epstein; B J Randle; S Finerty; J K Kirkwood
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

3.  Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay.

Authors:  Junji Sashihara; Peter D Burbelo; Barbara Savoldo; Theodore C Pierson; Jeffrey I Cohen
Journal:  Virology       Date:  2009-07-07       Impact factor: 3.616

4.  Recombinant vaccinia virus induces neutralising antibodies in rabbits against Epstein-Barr virus membrane antigen gp340.

Authors:  M Mackett; J R Arrand
Journal:  EMBO J       Date:  1985-12-01       Impact factor: 11.598

Review 5.  Antibody-profiling technologies for studying humoral responses to infectious agents.

Authors:  Peter D Burbelo; Kathryn H Ching; Emily R Bush; Brian L Han; Michael J Iadarola
Journal:  Expert Rev Vaccines       Date:  2010-06       Impact factor: 5.217

Review 6.  The 1986 Walter Hubert lecture. Recent studies on a vaccine to prevent EB virus-associated cancers.

Authors:  M A Epstein
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.